Stock NAT IFFE FUTURA, S.A.
Add to a list
To use this feature you must be a member
Log inSign up

Financials Iffe Futura, S.A.

Equities

NAT

ES0171613005

Pharmaceuticals

Market Closed - BME
Other stock markets
 11:35:18 2024-07-11 am EDT 		5-day change 1st Jan Change
0.64 EUR 0.00% Intraday chart for Iffe Futura, S.A. -0.78% -12.33%
Jun. 19 Iffe Futura, S.A. agreed to acquire Instituto De Formacion Financiera Y Empresarial, S.L. CI
2023 Iffe Futura, S.A. Reports Earnings Results for the Half Year Ended June 30, 2023 CI

Valuation

Fiscal Period: December 2017 2018 2019 2020 2021 2022
Capitalization 1 3.749 3.423 41.61 37.28 9.79 23.42
Enterprise Value (EV) 1 3.674 3.356 45.64 37.45 12.5 19.13
P/E ratio 9.27 x -13.9 x 114 x 62.1 x 126 x -7.61 x
Yield - - - - - -
Capitalization / Revenue 27.4 x 39.1 x 29.5 x 36.8 x 9.12 x 21.6 x
EV / Revenue 26.9 x 38.3 x 32.4 x 36.9 x 11.6 x 17.7 x
EV / EBITDA -85.7 x -68.3 x 629 x -154 x -237 x -19.7 x
EV / FCF -118 x -108 x 30.8 x -23 x -99.1 x -8.33 x
FCF Yield -0.85% -0.93% 3.25% -4.35% -1.01% -12%
Price to Book 0.56 x 0.55 x 1.04 x 0.91 x 0.27 x 0.56 x
Nbr of stocks (in thousands) 4,075 4,075 20,908 21,928 21,951 37,774
Reference price 2 0.9200 0.8400 1.990 1.700 0.4460 0.6200
Announcement Date 5/18/18 4/26/19 4/30/20 4/30/21 4/29/22 4/28/23
1EUR in Million2EUR
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2017 2018 2019 2020 2021 2022
Net sales 1 0.1367 0.0875 1.411 1.014 1.074 1.083
EBITDA 1 -0.0429 -0.0491 0.0726 -0.2426 -0.0528 -0.9722
EBIT 1 -0.0989 -0.0931 0.0286 -0.2905 -0.0915 -1.003
Operating Margin -72.34% -106.39% 2.02% -28.65% -8.52% -92.58%
Earnings before Tax (EBT) 1 0.4044 -0.2459 0.3619 0.449 0.1112 -4.491
Net income 1 0.4044 -0.2459 0.3291 0.6006 0.0815 -3.073
Net margin 295.74% -280.94% 23.33% 59.23% 7.59% -283.72%
EPS 2 0.0992 -0.0604 0.0175 0.0274 0.003543 -0.0814
Free Cash Flow 1 -0.0312 -0.0312 1.482 -1.63 -0.1261 -2.296
FCF margin -22.84% -35.65% 105.08% -160.8% -11.74% -211.96%
FCF Conversion (EBITDA) - - 2,041.46% - - -
FCF Conversion (Net income) - - 450.39% - - -
Dividend per Share - - - - - -
Announcement Date 5/18/18 4/26/19 4/30/20 4/30/21 4/29/22 4/28/23
1EUR in Million2EUR
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2022 2023 2024 2025
Net Debt - - - - - -
Net Cash position - - - - - -
Leverage (Debt/EBITDA) - - - - - -
Free Cash Flow - - - - - -
ROE (net income / shareholders' equity) - - - 52.3% 9.5% 15%
ROA (Net income/ Total Assets) - - - - - -
Assets - - - - - -
Book Value Per Share - - - - - -
Cash Flow per Share - - - - - -
Capex - - - - - -
Capex / Sales - - - - - -
Announcement Date 4/30/20 4/30/21 4/28/23 - - -
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Other Pharmaceuticals

1st Jan change Capi.
IFFE FUTURA, S.A. Stock Iffe Futura, S.A.
-12.33% 303M
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+60.25% 841B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+38.56% 625B
JOHNSON & JOHNSON Stock Johnson & Johnson
-4.49% 360B
MERCK & CO., INC. Stock Merck & Co., Inc.
+18.30% 327B
ABBVIE INC. Stock AbbVie Inc.
+9.64% 300B
ASTRAZENECA PLC Stock AstraZeneca PLC
+14.15% 242B
ROCHE HOLDING AG Stock Roche Holding AG
+3.11% 228B
NOVARTIS AG Stock Novartis AG
+16.98% 227B
AMGEN INC. Stock Amgen Inc.
+12.87% 174B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. NAT Stock
  4. Financials Iffe Futura, S.A.